First generation anti-CD19 chimeric antigen receptor-modified T cells for management of B cell malignances: initial analysis of an ongoing Phase I clinical trial

por Evans, Manon, Guest, Ryan, Rothwell, Dominic, Burt, Debbie, Kirillova, Natalia, Haughton, Jennifer, Chow, Shien, Thistlethwaite, Fiona, Gilham, David, Hawkins, Robert
Publicado 2014

5T4 oncofoetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype

por Castro, Fernanda V, McGinn, Owen J, Krishnan, Shekhar, Marinov, Georgi, Li, Jian, Rutkowski, Andrzej J, Elkord, Eyad, Burt, Debbie, Holland, Mark, Vaghjiani, Rasilaben, Gallego, Aurelia, Saha, Vaskar, Stern, Peter L
Publicado 2012